UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 124

Sortiert nach

International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancer

The lancet oncology, 2016-10, Vol.17 (10), p.e452-e466

2016

Link zum Volltext

Verfügbarkeit prüfen

Role of supportive care in improving the quality of life and reducing unscheduled hospital care in patients with metastatic breast cancer

Supportive care in cancer, 2021-07, Vol.29 (7), p.3735-3742

2021

Link zum Volltext

Verfügbarkeit prüfen

Venous Thromboembolism Prophylaxis and Treatment in Cancer: A Consensus Statement of Major Guidelines Panels and Call to Action

Journal of clinical oncology, 2009-10, Vol.27 (29), p.4919-4926

2009

Link zum Volltext

Verfügbarkeit prüfen

Three-Month Outcomes in Cancer Patients with Superficial or Deep Vein Thrombosis in the Lower Limbs: Results from the RIETE Registry

Cancers, 2023-03, Vol.15 (7), p.2034

2023

Link zum Volltext

Verfügbarkeit prüfen

Management and Research in Cancer Treatment-Related Cardiovascular Toxicity: Challenges and Perspectives

International journal of cardiology, 2016-12, Vol.224, p.366-375

2016

Link zum Volltext

Verfügbarkeit prüfen

Impact of venous thromboembolism on the natural history of pancreatic adenocarcinoma

Hepatobiliary & pancreatic diseases international, 2015-08, Vol.14 (4), p.436-442

2015

Link zum Volltext

Verfügbarkeit prüfen

Venous thromboembolism associated with central venous catheters in patients with cancer: From pathophysiology to thromboprophylaxis, areas for future studies

Journal of thrombosis and haemostasis, 2021-11, Vol.19 (11), p.2659-2673

2021

Link zum Volltext

Verfügbarkeit prüfen

Which events to consider in the study of venous thromboses in pancreatic cancer patients?

European journal of internal medicine, 2023-03, Vol.109, p.115-115

2023

Link zum Volltext

Verfügbarkeit prüfen

Withdrawal notice to « Patients sous Palbociclib et hormonothérapie pour un cancer du sein métastatique : peut-on prédire la survenue d’une hématotoxicité précoce et sévère ? » [Bull Cancer 108 (2021) 544–552 https://doi.org/10.1016/j.bulcan.2021.01.007]

Bulletin du cancer, 2024-01, Vol.111 (1), p.124

2024

Link zum Volltext

Verfügbarkeit prüfen

Incidence of venous thromboembolism and discriminating capacity of Khorana score in lung cancer patients treated with immune checkpoint inhibitors

Journal of thrombosis and thrombolysis, 2022-08, Vol.54 (2), p.287-294

2022

Link zum Volltext

Verfügbarkeit prüfen

Patients treated with palbociclib and endocrine therapy for metastatic breast cancer: Can we predict the occurrence of severe early hematological toxicity?

Bulletin du cancer, 2021-05, Vol.108 (5), p.544

2021

Link zum Volltext

Verfügbarkeit prüfen

Involvement of Platelet-Derived Microparticles in Tumor Progression and Thrombosis

Seminars in oncology, 2014-06, Vol.41 (3), p.346-358

2014

Link zum Volltext

Verfügbarkeit prüfen

WITHDRAWN: Patients sous palbociclib et hormonothérapie pour un cancer du sein métastatique : peut-on prédire la survenue d’une hématotoxicité précoce et sévère ?

Bulletin du cancer, 2021-05, Vol.108 (5), p.544-552

2021

Link zum Volltext

Verfügbarkeit prüfen

Patients sous palbociclib et hormonothérapie pour un cancer du sein métastatique : peut-on prédire la survenue d’une hématotoxicité précoce et sévère ?

Bulletin du cancer, 2021-05, Vol.108 (5), p.544-552

2021

Link zum Volltext

Verfügbarkeit prüfen

Recurrent venous thromboembolism in anticoagulated patients with cancer: management and short‐term prognosis

Journal of thrombosis and haemostasis, 2015-06, Vol.13 (6), p.1010-1018

2015

Link zum Volltext

Verfügbarkeit prüfen

Implementing thrombosis guidelines in cancer patients: a review

Rambam Maimonides medical journal, 2014-10, Vol.5 (4), p.e0041-e0041

2014

Link zum Volltext

Verfügbarkeit prüfen

A Pragmatic Study Evaluating NEPA Versus Aprepitant for Prevention of Chemotherapy‐Induced Nausea and Vomiting in Patients Receiving Moderately Emetogenic Chemotherapy

The oncologist (Dayton, Ohio), 2021-10, Vol.26 (10), p.e1870-e1879

2021

Link zum Volltext

Verfügbarkeit prüfen

Central venous catheter associated upper extremity deep vein thrombosis in cancer patients: Diagnosis and therapeutic management

Archives of cardiovascular diseases, 2024-01, Vol.117 (1), p.72-83

2024

Link zum Volltext

Verfügbarkeit prüfen

Treatment of cancer-associated venous thromboembolism in patients under palliative care

Archives of cardiovascular diseases, 2024-01, Vol.117 (1), p.94-100

2024

Link zum Volltext

Verfügbarkeit prüfen

Risk of recurrent venous thromboembolism in patients with autoimmune diseases: data from the Registro Informatizado de Enfermedad TromboEmbólica (RIETE) registry

British journal of haematology, 2021-07, Vol.194 (1), p.195-199

2021

Link zum Volltext

Verfügbarkeit prüfen

Non-compliance with end-of-life parenteral nutrition prescription recommendations: retrospective study of 1,260 cancer patients

Annals of palliative medicine, 2022-11, Vol.11 (11), p.3417-3425

2022

Link zum Volltext

Verfügbarkeit prüfen

Dalteparin or vitamin K antagonists to prevent recurrent venous thromboembolism in cancer patients: a patient-level economic analysis for France and Austria

Supportive care in cancer, 2017-07, Vol.25 (7), p.2093-2102

2017

Link zum Volltext

Verfügbarkeit prüfen

Low-molecular-weight heparins for cancer-associated thromboembolism: What place in 2019?

Bulletin du cancer, 2020-02, Vol.107 (2), p.224

2020

Link zum Volltext

Verfügbarkeit prüfen

Héparines de bas poids moléculaires dans la maladie thromboembolique veineuse liée au cancer : quelle place en 2019 ?

Bulletin du cancer, 2020-02, Vol.107 (2), p.224-233

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 124

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(107)
Mit Volltextzugriff
(106)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancer

Role of supportive care in improving the quality of life and reducing unscheduled hospital care in patients with metastatic breast cancer

Venous Thromboembolism Prophylaxis and Treatment in Cancer: A Consensus Statement of Major Guidelines Panels and Call to Action

Three-Month Outcomes in Cancer Patients with Superficial or Deep Vein Thrombosis in the Lower Limbs: Results from the RIETE Registry

Management and Research in Cancer Treatment-Related Cardiovascular Toxicity: Challenges and Perspectives

Impact of venous thromboembolism on the natural history of pancreatic adenocarcinoma

Venous thromboembolism associated with central venous catheters in patients with cancer: From pathophysiology to thromboprophylaxis, areas for future studies

Which events to consider in the study of venous thromboses in pancreatic cancer patients?

Withdrawal notice to « Patients sous Palbociclib et hormonothérapie pour un cancer du sein métastatique : peut-on prédire la survenue d’une hématotoxicité précoce et sévère ? » [Bull Cancer 108 (2021) 544–552 https://doi.org/10.1016/j.bulcan.2021.01.007]

Incidence of venous thromboembolism and discriminating capacity of Khorana score in lung cancer patients treated with immune checkpoint inhibitors

Patients treated with palbociclib and endocrine therapy for metastatic breast cancer: Can we predict the occurrence of severe early hematological toxicity?

Involvement of Platelet-Derived Microparticles in Tumor Progression and Thrombosis

WITHDRAWN: Patients sous palbociclib et hormonothérapie pour un cancer du sein métastatique : peut-on prédire la survenue d’une hématotoxicité précoce et sévère ?

Patients sous palbociclib et hormonothérapie pour un cancer du sein métastatique : peut-on prédire la survenue d’une hématotoxicité précoce et sévère ?

Recurrent venous thromboembolism in anticoagulated patients with cancer: management and short‐term prognosis

Implementing thrombosis guidelines in cancer patients: a review

A Pragmatic Study Evaluating NEPA Versus Aprepitant for Prevention of Chemotherapy‐Induced Nausea and Vomiting in Patients Receiving Moderately Emetogenic Chemotherapy

Central venous catheter associated upper extremity deep vein thrombosis in cancer patients: Diagnosis and therapeutic management

Treatment of cancer-associated venous thromboembolism in patients under palliative care

Risk of recurrent venous thromboembolism in patients with autoimmune diseases: data from the Registro Informatizado de Enfermedad TromboEmbólica (RIETE) registry

Non-compliance with end-of-life parenteral nutrition prescription recommendations: retrospective study of 1,260 cancer patients

Dalteparin or vitamin K antagonists to prevent recurrent venous thromboembolism in cancer patients: a patient-level economic analysis for France and Austria

Low-molecular-weight heparins for cancer-associated thromboembolism: What place in 2019?

Héparines de bas poids moléculaires dans la maladie thromboembolique veineuse liée au cancer : quelle place en 2019 ?

Suchergebnisse filtern